Forward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trial
In this discussion, Suzanne Baron, MD, FSCAI, Zach Gertz, MD, Gregg W. Stone, MD, MSCAI, and Lissa Sugeng, MD, FSCAI, highlight key findings from the JSCAI article on the impact of forward flow in heart failure (HF) patients undergoing mitral transcatheter edge-to-edge repair (TEER). The panel discusses data from the COAPT trial, which stratified patients by baseline forward flow and assessed outcomes with TEER plus guideline-directed medical therapy (GDMT) versus GDMT alone. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.102609